Simulations Plus Announces ClassPharmer Sales Success

Published: Oct 09, 2006

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today results of its recent investments to acquire and advance its ClassPharmerâ„¢ product line. The Company has received revenues and purchased accounts receivable from its acquisition last year of certain assets of the former Bioreason, Inc., and Sage Informatics, LLC, that have exceeded the original acquisition costs.

Back to news